Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease

被引:0
|
作者
Lapucci, Caterina [1 ]
Boccia, Vincenzo Daniele [2 ]
Clementi, Thoma Dario [2 ]
Schiavi, Simona [2 ]
Benedetti, Luana [1 ]
Uccelli, Antonio [1 ,2 ]
Novi, Giovanni [1 ]
Cellerino, Maria [2 ]
Inglese, Matilde [1 ,2 ]
机构
[1] IRCCS Osped Policlin San Martino, Largo Daneo 3, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
关键词
neuromyelitis optica spectrum disorder; myelin oligodendrocyte glycoprotein antibody-associated disease; MRI; diffusion; microstructure;
D O I
10.1111/jon.13218
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) diagnosis are based on the presence of serological and magnetic resonance imaging (MRI) biomarkers. Diffusion tensor imaging (DTI), neurites orientation dispersion and density imaging (NODDI), and the Spherical Mean Technique (SMT) may be helpful to provide a microstructural characterization of the different types of white matter lesions and give an insight about their different pathological mechanisms. The aim of the study was to characterize microstructural differences between brain typical lesions (TLs) and nontypical lesions (nTLs). Methods A total of 17 NMOSD and MOGAD patients [9 Aquaporin4 (AQP4) + NMO, 2 seronegative-NMO, 6 MOGAD] underwent MRI scans on a 3 Tesla MAGNETON PRISMA. Diffusion parameters (fractional anisotropy; mean diffusivity [MD]; intracellular volume fraction [ICVF]; extra-neurite transverse diffusivity; and extra-neurite MD; neurite signal fraction) were obtained using DTI, NODDI, and SMT. Microstructural parameters within lesions were compared through a generalized linear model using age, sex, and total lesion volume as covariates. Results In NMOSD/MOGAD whole cohort (total lesions = 477), TLs showed increased MD and decreased ICVF compared to nTLs (p < .05), indicating higher inflammation and axonal loss. Similar results were found also in the AQP4 + NMO subgroup (decreased ICVF, p < .05). Furthermore, in NMOSD/MOGAD whole cohort and in AQP4 + NMO subgroup, TLs showed a trend toward higher EXRATRANS than nTLs, suggesting a more severe degree of demyelination within TLs. Conclusions TLs and nTLs in NMOSD/MOGAD showed different diffusion MRI-derived microstructural features, with TLs showing a more severe degree of inflammation and fiber disruption with respect to nTLs.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
  • [2] Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder
    Ungureanu, A.
    de Seze, J.
    Ahle, G.
    Sellal, F.
    REVUE NEUROLOGIQUE, 2018, 174 (10) : 675 - 679
  • [3] Dysphagia in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody disease as a surrogate of brain involvement?
    Pawlitzki, Marc
    Ahring, Sigrid
    Rolfes, Leoni
    Dziewas, Rainer
    Warnecke, Tobias
    Suntrup-Krueger, Sonja
    Wiendl, Heinz
    Klotz, Luisa
    Meuth, Sven G.
    Labeit, Bendix
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (05) : 1765 - 1770
  • [4] Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein AntibodyAssociated Disease
    Rees, John H.
    Rempe, Torge
    Tuna, Ibrahim Sacit
    Perero, Mayra Montalvo
    Sabat, Shyamsunder
    Massini, Tara
    Yetto Jr, Joseph M.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2024, 32 (02) : 233 - 251
  • [5] Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder
    Salama, Sara
    Pardo, Santiago
    Levy, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 231 - 235
  • [6] Myelin oligodendrocyte glycoprotein antibody-associated disease mimicking neuromyelitis optica spectrum disorder
    Sakthivel, Siva
    Shruthi, T. K.
    James, Saji
    Manokaran, Ranjithkumar
    BMJ CASE REPORTS, 2025, 18 (01)
  • [7] Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
    Dinoto, Alessandro
    Sechi, Elia
    Flanagan, Eoin P.
    Ferrari, Sergio
    Solla, Paolo
    Mariotto, Sara
    Chen, John J.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [8] Referral bias impacts cohorts of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease
    Rato, Miguel Leal
    O'Sullivan, Eoin
    Cooper, Sarah
    Fisniku, Leonora
    Halfpenny, Christopher
    Martin, Roswell
    Luppe, Sebastian
    Hobart, Jeremy
    Rashid, Waqar
    Hemingway, Cheryl
    Dobson, Ruth
    Ramdas, Sithara
    Leite, Maria Isabel
    Geraldes, Ruth
    Palace, Jacqueline
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 404 - 405
  • [9] Longitudinal Spinal Cord Atrophy Patterns in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Neuromyelitis Optica Spectrum Disorder
    Amin, Moein
    Nakamura, Kunio
    Ontaneda, Daniel
    Kunchok, Amy
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 270 - 270
  • [10] Review of Cardiovascular Comorbidities and Risk Factors in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody Disease
    Samadzadeh, Sara
    Chan, Fiona
    Barzegareskandarkolaei, Mahdi
    Bidares, Matin
    Hosseini, Nastaran
    Bennett, Jeffrey L.
    Weinshenker, Brian
    Geraldes, Ruth
    Palace, Jacqueline
    Paul, Friedemann
    Asgari, Nasrin
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 718 - 719